Cargando…

SARS: screening, disease associations, and response

Detalles Bibliográficos
Autor principal:	Baker, Simon J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2003
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134885/ https://www.ncbi.nlm.nih.gov/pubmed/12788592 http://dx.doi.org/10.1016/S0140-6736(03)13508-8

Ejemplares similares

SARS: screening, disease associations, and response
por: Sloan, Richard EG
Publicado: (2003)

To screen, or not to screen for SARS-Cov2
por: Muula, Adamson S
Publicado: (2020)

Border Screening for SARS
por: St. John, Ronald K., et al.
Publicado: (2005)

SARS-CoV-2 and Pre-existing Vascular Diseases: Guilt by Association?
por: Voulalas, Grigorios, et al.
Publicado: (2021)

Identification of transcriptional regulatory network associated with response of host epithelial cells to SARS-CoV-2
por: Su, Chen, et al.
Publicado: (2021)

Are caregiving responsibilities associated with non-attendance at breast screening?
por: Kinnear, Heather, et al.
Publicado: (2010)

Anti-SARS drug screening by molecular docking
por: Wei, D.-Q., et al.
Publicado: (2006)

Alteration of the kynurenine pathway is inversely associated with the humoral immune response in patients with SARS-CoV-2
por: Michaelis, Simon, et al.
Publicado: (2022)

A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease
por: Baker, Jeremy D., et al.
Publicado: (2021)

Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection
por: Libraty, Daniel H., et al.
Publicado: (2007)

Spike Antibody Assays Can Screen For Viral Neutralizing Activity Toward SARS-CoV-2
por: Schuler, Charles, et al.
Publicado: (2022)

Mechanism-Based Screen Establishes Signalling Framework for DNA Damage-Associated G1 Checkpoint Response
por: Richardson, Elizabeth, et al.
Publicado: (2012)

Screening for Parkinson's disease with response time batteries: A pilot study
por: Johnson, Andrew M, et al.
Publicado: (2004)

Deciphering the quality of SARS‐CoV‐2 specific T‐cell response associated with disease severity, immune memory and heterologous response
por: Pérez‐Gómez, Alberto, et al.
Publicado: (2022)

SARS – Unprecedented global response to a newly emerging disease
por: Ziebuhr, John
Publicado: (2003)

Screening of genes associated with inflammatory responses in the endolymphatic sac reveals underlying mechanisms for autoimmune inner ear diseases
por: Zhang, Juhong, et al.
Publicado: (2018)

Light Yield Response of Neutron Scintillation Screens to Sudden Flux Changes
por: Neuwirth, Tobias, et al.
Publicado: (2020)

Smartphone-controlled biosensor for viral respiratory infectious diseases: Screening and response
por: Ma, Yaxing, et al.
Publicado: (2023)

Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease
por: Balakrishnan, Vijayakumar, et al.
Publicado: (2020)

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
por: Röltgen, Katharina, et al.
Publicado: (2020)

Novel Plasmodium antigens identified via genome-based antibody screen induce protection associated with polyfunctional T cell responses
por: Schussek, Sophie, et al.
Publicado: (2017)

Pathophysiological Response to SARS-CoV-2 Infection Detected by Infrared Spectroscopy Enables Rapid and Robust Saliva Screening for COVID-19
por: Kazmer, Seth T., et al.
Publicado: (2022)

Association of Age With SARS-CoV-2 Antibody Response
por: Yang, He S., et al.
Publicado: (2021)

HLA alleles, disease severity, and age associate with T-cell responses following infection with SARS-CoV-2
por: Olafsdottir, Thorunn A., et al.
Publicado: (2022)

The prevalence of osteonecrosis in 448 SARS patients: a screening study with MRI
por: Cheng, X.G., et al.
Publicado: (2006)

Inflammatory responses in SARS-CoV-2 associated Multisystem Inflammatory Syndrome and Kawasaki Disease in children: An observational study
por: Biesbroek, G., et al.
Publicado: (2022)

Mucosal gene expression in response to SARS-CoV-2 is associated with early viral load
por: Rajagopala, Seesandra V., et al.
Publicado: (2022)

IS UNIVERSAL SCREENING OF IVF PATIENTS FOR SARS-COV-2 JUSTIFIED?
por: Seidman, Daniel S., et al.
Publicado: (2020)

Rapid response research to emerging infectious diseases: lessons from SARS
por: Finlay, B. Brett, et al.
Publicado: (2004)

Evaluation of sample pooling for screening of SARS CoV-2
por: Mulu, Andargachew, et al.
Publicado: (2021)

Using internet search queries for infectious disease surveillance: screening diseases for suitability
por: Milinovich, Gabriel J, et al.
Publicado: (2014)

Exploring parents' screen-viewing behaviours and sedentary time in association with their attitudes toward their young child's screen-viewing
por: Solomon-Moore, Emma, et al.
Publicado: (2017)

Earlier and widespread screening for SARS-CoV-2 is needed for first responders
por: Tang, Olive, et al.
Publicado: (2021)

Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load
por: Rajagopala, Seesandra V., et al.
Publicado: (2023)

Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
por: Scorza, Fulvio A., et al.
Publicado: (2021)

A rapid RT-LAMP SARS-CoV-2 screening assay for collapsing asymptomatic COVID-19 transmission
por: Allsopp, Rebecca C., et al.
Publicado: (2022)

SARS Preparedness and Response Planning
por: Parashar, Umesh D., et al.
Publicado: (2004)

SARS-COV-2 vaccine responses in renal patient populations
por: Smith, Rona M., et al.
Publicado: (2022)

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication
por: Garcia, Gustavo, et al.
Publicado: (2021)

Thermal Image Scanning for Influenza Border Screening: Results of an Airport Screening Study
por: Priest, Patricia C., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bttuhr6vcqd2u4guch22e0sedq